Tango Therapeutics, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -678.84%-156.43%-434.92%-278.18%-309.24%
EBIT Margin -681.82%-157.09%-446.79%-312.57%-346.09%
EBITDA Margin -678.75%-159.32%-446.97%-267.89%-309.38%
Operating Margin -681.82%-157.09%-446.79%-312.57%-346.09%
Net Margin -678.84%-157.24%-435.33%-278.54%-309.73%
FCF Margin 900.84%-165.66%-469.72%-327.18%-314.38%
Efficiency
Assets Average 353.70M468.31M419.52M359.53M
Equity Average 191.67M297.11M251.29M226.31M
Invested Capital 38.60M344.75M249.48M253.11M199.52M
Asset Utilization Ratio 0.100.050.090.12
Leverage & Solvency
Equity Ratio 0.190.690.570.630.63
Valuation
Enterprise Value 45.12M470.22M273.15M669.39M74.00M
Market Capitalization 237.72M957.76M639.29M1,009.70M331.92M
Return Ratios
Return on Sales -6.79%-1.57%-4.35%-2.79%-3.10%
Return on Capital Employed -0.19%-0.27%-0.31%-0.45%
Return on Assets -0.16%-0.23%-0.24%-0.36%
Return on Equity -0.30%-0.36%-0.40%-0.58%